Cationic Lipid Nanoparticles for Nucleic Acid Protection and Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering nucleic acids face challenges such as susceptibility to nuclease digestion in plasma and limited intracellular access, necessitating improved cationic lipids and lipid nanoparticles that protect nucleic acids from degradation and facilitate cellular uptake.
Innovation Solution
Development of novel cationic lipids that form lipid nanoparticles with other lipid components to shield nucleic acids from degradation and enhance intracellular delivery, including formulations with neutral lipids, cholesterol, and polymer conjugated lipids.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If free nucleic acids are administered, then they can potentially reach intracellular targets, but they are susceptible to nuclease digestion in plasma and have limited ability to gain access to the intracellular compartment
Solution Approach 1:
The patent employs lipid nanoparticles as intermediary carriers to deliver nucleic acids. The cationic lipids in the nanoparticle formulation interact with the anionic nucleic acids to form protected complexes that can navigate through plasma without nuclease degradation and facilitate cellular uptake through endocytosis, thus mediating protection and delivery functions.
Solution Approach 2:
The lipid nanoparticle forms a flexible protective shell around the nucleic acid payload. This lipid bilayer structure protects the encapsulated nucleic acids from external degradation by nucleases in plasma while allowing the particle to interact with cell membranes and facilitate intracellular delivery through endocytic pathways.
2Productivity
If lipid nanoparticles are used to protect nucleic acids and facilitate cellular uptake, then delivery efficiency improves, but the complexity of the delivery system increases
Solution Approach 1:
The patent utilizes composite lipid nanoparticle formulations composed of multiple lipid components including ionizable cationic lipids, neutral lipids, and cholesterol. This composite material approach enables the nanoparticle to simultaneously provide nucleic acid complexation, structural stability, and cellular uptake facilitation, thereby improving delivery efficiency while managing formulation complexity through synergistic component interactions.
Solution Approach 2:
The patent employs ionizable cationic lipids that undergo parameter changes in response to pH gradients. These lipids are cationic at acidic pH (facilitating nucleic acid binding and endosomal escape) but become neutral at physiological pH (reducing toxicity and improving circulation). This parameter change capability allows a single lipid component to perform multiple functions across different biological compartments.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel lipid nanoparticles provide increased activity and tolerability of nucleic acids, improving the therapeutic index by enhancing protection and cellular delivery, enabling effective expression or inhibition of target proteins.
Implementation Method 1
Lipid nanoparticles formed from cationic lipids with other lipid components have been used to block degradation of the RNAs in plasma
Implementation Method 2
Lipid nanoparticles formed from cationic lipids with other lipid components, such as neutral lipids, cholesterol, PEG, PEGylated lipids, and oligonucleotides
Implementation Method 3
facilitate the cellular uptake of the oligonucleotides
Implementation Method 4
facilitate the intracellular delivery of therapeutic nucleic acids
Data Source
AI summary
Compounds are provided having the following structure:or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein R1, R2, R3, R4, R5, L1, L2, L3, G1, G2, and G3 are as defined herein. Use of the compounds as a component of lipid nanoparticle formulations for delivery of a therapeutic agent, compositions comprising the compounds and methods for their use and preparation are also provided.